Replies to post #14062 on Cel Sci Corporation (CVM)

[lightrock]

From the article:
"The emerging data are also showing more clearly how the effectiveness of immunotherapy drugs drops after patients receive chemotherapy, he explained: Immunotherapy benefits about 60 percent of patients who have never gotten chemo, 40 percent who received one round of chemo and just 20 percent after two or more rounds."

If you follow the story line of CVM Multikine, then the theory to apply immunotherapy first appears to be very wise.

But, may possibly be compromised by the chemo, depending on how you read that.

I guess that's what we're going to find out

And "Oops"... dang, now I have to go back and see what it means if anything if I try to say "60% of the test group will respond".

I think only it will mean The Oncologist numbers at 5 years are even more important than the SA article numbers.